Cancer
📧 Sign up to get email alerts when something new happens for Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-04-11Clinical Trial Update: Effects of Pet Therapy on Pain in Cancer Patients [Phase 2]
A Phase 2 clinical trial evaluating the effects of pet therapy on pain in cancer patients has completed enrollment and results.
-
CLINICAL_TRIALS trial_result · 2019-04-05Clinical Trial Update: Clinical Study of WT2725 in Patients With Advanced Malignancies [Phase 1]
Phase 1 clinical trial update for WT2725 in patients with advanced cancers; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-04-01Clinical Trial Update: Dose Escalation Study With MK-2206 in Patients With Locally Advanced or Metastatic Solid Tumors (MK-2206-002) [Phase 1]
Phase 1 dose-escalation trial of MK-2206 in locally advanced or metastatic solid tumors completed; results posted.
-
CLINICAL_TRIALS trial_result · 2019-04-01Clinical Trial Update: A Dose-Escalation Study in Participants With Advanced Cancer [Phase 1]
Phase 1 dose-escalation study in participants with advanced cancer has completed; results posted.
-
FDA approval · 2019-03-28FDA Approved: GRANIX — Supplemental Application (Cephalon, LLC)
FDA approved a supplemental application for GRANIX (tbo-filgrastim) submitted by Cephalon, LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-03-26Clinical Trial Update: The Use of Light Therapy for Managing Sleep Disturbances in Patients With Advanced Cancer [Phase 2, Phase 3]
Clinical trial investigating light therapy for sleep disturbances in patients with advanced cancer; the study completed (terminated) with re…
-
FDA approval · 2019-03-21FDA Approved: FULPHILA — Supplemental Application (Biocon Biologics Inc.)
FDA supplemental approval for Fulphila (pegfilgrastim-jmdb) by Biocon Biologics Inc. to update/expand the approved labeling for this biosimi…
-
CLINICAL_TRIALS trial_result · 2019-03-18Clinical Trial Update: A Tasisulam and Midazolam Drug Interaction Study in Cancer Patients [Phase 1]
Phase 1 study evaluating interaction between tasisulam and midazolam in advanced cancer patients; study terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2019-03-15Clinical Trial Update: Study is Designed to Assess the Safety and Tolerability of AZD4547 at Increasing Doses in Patients With Advanced Tumours [Phase 1]
A Phase 1 trial evaluating safety and tolerability of AZD4547 at increasing doses in patients with advanced solid tumors was terminated; res…
-
CLINICAL_TRIALS trial_result · 2019-03-13Clinical Trial Update: N-of-1 Trial: Actionable Target Identification in Metastatic Cancer for Palliative Systemic Therapy [Phase 2]
Phase 2 N-of-1 trial focused on actionable target identification in metastatic cancer for guiding palliative systemic therapy.
-
CLINICAL_TRIALS trial_result · 2019-03-05Clinical Trial Update: Tolerability, Safety, and Feasibility of Naloxegol in Patients With Cancer and OIC (Opioid Induced Constipation) [Phase 4]
Phase 4 trial evaluating tolerability, safety, and feasibility of naloxegol for opioid-induced constipation in cancer patients; study termin…
-
CLINICAL_TRIALS trial_result · 2019-03-04Clinical Trial Update: A Dose-escalation Study to Evaluate the Safety, Tolerability, and Antitumor Activity of MEDI-573 in Subjects With Advanced Solid Tumors [Phase 1]
Phase 1 dose-escalation study evaluating MEDI-573 for safety, tolerability, and antitumor activity in advanced solid tumors; completed with …
-
CLINICAL_TRIALS trial_result · 2019-02-25Clinical Trial Update: A Study of LY2090314 in Patients With Advanced or Metastatic Cancer [Phase 1]
Phase 1 study of LY2090314 in patients with advanced or metastatic cancer has completed with results posted.
-
CLINICAL_TRIALS research · 2019-02-22Clinical Trial Update: The Interest of Cancer Patients and Caregivers in Acupuncture: a Survey [NA]
A completed survey examining cancer patients and caregivers' interest in acupuncture.
-
CLINICAL_TRIALS trial_result · 2019-02-21Clinical Trial Update: Immuno Positron Emission Tomography Study of GSK2849330 in Subjects With Human Epidermal Growth Factor Receptor 3-Positive Solid Tumors [Phase 1]
A Phase 1 immuno-PET imaging study of GSK2849330 in HER3-positive solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2019-02-21Clinical Trial Update: SPOG 2015 FN Definition. A Multi-center Non-inferiority Trial on Safety of a High Versus Low Temperature Limit Defining Fever in Pediatric Patients With Cancer at Risk for Fever in Chemotherapy-induced Neutropenia [NA]
This is a completed multi-center non-inferiority trial comparing high versus low temperature thresholds to define fever in pediatric cancer …
-
CLINICAL_TRIALS trial_result · 2019-02-21Clinical Trial Update: Dose-finding and Pharmacokinetic Study of DpC, Administered Orally to Patients With Advanced Solid Tumors [Phase 1]
Phase 1 dose-finding and pharmacokinetic study of DpC in patients with advanced solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2019-02-19Clinical Trial Update: GSK1120212 Rollover Study [Phase 2]
A Phase 2 rollover study of GSK1120212 (trametinib) sponsored by Novartis was terminated, and results were posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: A Study of Radiation With Sorafenib in Advanced Cancer [Phase 1]
The document reports the completion of a Phase 1 trial evaluating the combination of radiation therapy with sorafenib in patients with advan…
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Enhancing Connections Program in Improving Communication Between Patients With Incurable Cancer and Their Children [NA]
Completed clinical trial evaluating the Enhancing Connections Program to improve communication between patients with incurable cancer and th…
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Stereotactic Radiosurgery for Patients With Hepatic Metastases. [Phase 1]
Phase 1 trial update for stereotactic radiosurgery in patients with liver metastases; the study status is completed.
-
CLINICAL_TRIALS research · 2019-02-15Clinical Trial Update: Laboratory Testing for Tie-2 Expressing Monocytes (TEMs) in Blood
This clinical trial update describes laboratory testing of Tie-2 expressing monocytes (TEMs) in blood from participants with advanced cancer…
-
CLINICAL_TRIALS trial_result · 2019-02-12Clinical Trial Update: Pharmacokinetics of Tivantinib in Subjects With Advanced Solid Tumors and Hepatic Impairment [Phase 1]
Phase 1 pharmacokinetic study of tivantinib in adults with advanced solid tumors and hepatic impairment, reporting PK parameters in these po…
-
CLINICAL_TRIALS trial_result · 2019-02-12Clinical Trial Update: Safety Study of Oral MGCD265 Administered Without Interruption to Subjects With Advanced Malignancies [Phase 1]
This document reports the completion of a Phase 1 safety study of MGCD265 in subjects with advanced malignancies.
-
CLINICAL_TRIALS other · 2019-02-11Clinical Trial Update: Consent for Obtaining Additional Bone Marrow Specimens at Time of Diagnostic Bone Marrow Procedure
This clinical trial update addresses consent for obtaining additional bone marrow specimens at the time of diagnostic bone marrow procedures…